Adina Wise

ORCID: 0000-0002-3982-8505
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Parkinson's Disease Mechanisms and Treatments
  • Lysosomal Storage Disorders Research
  • Neurological diseases and metabolism
  • Atrial Fibrillation Management and Outcomes
  • Venous Thromboembolism Diagnosis and Management
  • Sleep and related disorders
  • Autism Spectrum Disorder Research
  • Urban Transport and Accessibility
  • Sleep and Wakefulness Research
  • Cellular transport and secretion
  • Acute Ischemic Stroke Management
  • RNA Research and Splicing
  • Retinal Development and Disorders
  • Glycogen Storage Diseases and Myoclonus
  • Children's Physical and Motor Development
  • Neurogenetic and Muscular Disorders Research
  • Circadian rhythm and melatonin
  • Nuclear Receptors and Signaling
  • Assistive Technology in Communication and Mobility
  • Metabolism and Genetic Disorders
  • Medical Coding and Health Information
  • Neurological disorders and treatments
  • RNA regulation and disease
  • Electronic Health Records Systems
  • Alzheimer's disease research and treatments

Icahn School of Medicine at Mount Sinai
2022-2024

Mount Sinai Beth Israel
2023-2024

University of Milan
2022

Ospedale Maggiore
2022

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
2022

Tel Aviv Sourasky Medical Center
2022

Mount Sinai Health System
2020

Columbia University Irving Medical Center
2017

Columbia University
2014-2016

Recent research has suggested a possible link between Parkinson's disease (PD) and Fabry disease. To test this relationship, we administered self-report family history questionnaire to determine the prevalence of PD in patients members with likely pathogenic alpha-galactosidase A (GLA) mutations. total 90 (77 from online survey 13 Icahn School Medicine at Mount Sinai (ISMMS)) were included analysis. Two who completed diagnosed (2/90, 2.2%). Among probands older than 60, 8.3% (2/24) PD. Using...

10.1016/j.ymgmr.2017.10.013 article EN cc-by Molecular Genetics and Metabolism Reports 2017-11-08

10.1016/bs.pbr.2022.01.015 article EN Progress in brain research 2022-01-01

Carbidopa-levodopa has been used for more than 50 years in the treatment of Parkinson disease (PD) and other movement disorders. Pyridoxal 5'-phosphate (PLP), an active form vitamin B6 (pyridoxine), is involved decarboxylation levodopa to dopamine; carbidopa, which combined with reduce peripheral conversion minimize dopamine side effects, binds irreversibly PLP. As a result, carbidopa-levodopa may cause deficiency associated sequelae, including seizures, especially high doses. A 78-year-old...

10.1159/000525234 article EN cc-by-nc Case Reports in Neurology 2022-06-27

variants have been associated with immune dysregulation as well immune-related disorders such IBD. A possible relationship between multiple sclerosis (MS) and

10.3389/fneur.2024.1450654 article EN cc-by Frontiers in Neurology 2024-08-08

Parkinson disease is a chronic and multifaceted neurodegenerative disorder that necessitates specialized integrated care. By engaging with multidisciplinary team, including movement disorders specialist, physical therapist, speech-language pathologist, occupational dietician social worker, patients may become familiar and, eventually, adept at skills have the potential to improve quality of life. Many feel overwhelmed by plurality providers involved in management their long-term condition....

10.3389/fneur.2017.00364 article EN cc-by Frontiers in Neurology 2017-07-27

Dating back to ancient civilizations when records were carefully transcribed onto papyrus, clinical documentation has long served as a cornerstone of medical-and especially neurologic-education. From the case histories Hippocrates diurnal patient logs used by trainees in 18th and 19th centuries, notes have an extended history invaluable instruments pedagogy, scholarly practice, interprofessional communication. The novel paradigm introduced Lawrence Weed 1950s, advocating for problem-oriented...

10.1212/ne9.0000000000200147 article EN Neurology Education 2024-09-01

Molecular therapies exploit the understanding of pathogenic mechanisms to reconstitute impaired gene function or manipulate flawed RNA expression. These include (1) interference by antisense oligonucleotides, (2) mRNA modification using small molecules, and (3) replacement therapy, viral-mediated intracellular delivery exogenous nucleic acids reverse a genetic defect. Several molecular are approved for treating spinal muscular atrophy (SMA), recessive disorder caused survival motor neuron...

10.1212/wnl.0000000000201294 article EN Neurology 2022-11-01

10.1212/wnl.0000000000207169 article EN Neurology 2023-04-18

<h3>Objective:</h3> To assess the effects of a short-term tailored lighting intervention therapy (TLI) on sleep disturbances in Parkinson disease (PD). <h3>Background:</h3> Sleep are common non-motor symptom PD, adversely affecting quality life, mood and cognition. They suggest underlying disruptions circadian rhythm. Based our preliminary studies showing positive impacts TLI sleep, behavior Alzheimer's disease, we hypothesize that can improve objective measures PD. <h3>Design/Methods:</h3>...

10.1212/wnl.0000000000202783 article EN Neurology 2023-04-25
Coming Soon ...